Wednesday, January 15, 2025 10:58:47 AM
No, Advent has a sublease on the GMPO approved portion of the facility that lasts as long as NWBO has the master lease. This is clearly described in the sublease contract on Edgar. That contract specifically notes in Exhibit A at the end that it includes 4 hotel cleanroom suites (2 completed, 2 planned), labs and cryostorage freeers.. So those are Advents.
The total subleased space is about 14k sq feet. That agrees with what has been PR'd as the initial GMP space plus the expansion.
One can also see in the latest 10Q that most all of the value put into the facility since the sale/lease/sublease is in the form of leasehold improvements. 18.7M in leasehold improvements vs $3.2M in computer and manufacturing equipment. It is a very safe bet that the vast majority of the leasehold improvements are in Advents subleased space.
And finally, most of the GMP license is not for the facility but for the implemented operations. That is all Advent.
The total subleased space is about 14k sq feet. That agrees with what has been PR'd as the initial GMP space plus the expansion.
One can also see in the latest 10Q that most all of the value put into the facility since the sale/lease/sublease is in the form of leasehold improvements. 18.7M in leasehold improvements vs $3.2M in computer and manufacturing equipment. It is a very safe bet that the vast majority of the leasehold improvements are in Advents subleased space.
And finally, most of the GMP license is not for the facility but for the implemented operations. That is all Advent.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
